Through the power of AI, we revolutionize neuro-monitoring.
Introducing the most advanced smartphone-based pupillometer for critical care.
Pupil assessment reveals key neurological insights but is often subjective or reliant on costly, bulky devices.
of intensive care nurses express the need for better pupil assessment.
need a second opinion following pupil examination with a penlight.
notice reactivity difference in pupillometer / visual inspection comparison.
*As found among ICU nursing professionals at Oxford University Hospitals NHS Foundation Trust and published at Mayo Clinic’s 9th Annual Neuro and Intensive Care in May 2023
Assessment of the pupil in ICU: How accurate and confident are your nurses at performing their assessments?
Chrapkiewicz, R, Ph.D. (Solvemed Inc.), Neffendorf, JE, M.D. (King’s College Hospital NHS Foundation Trust), Sivakanthan M (King’s College London), Raby, S, M.D. (Oxford University Hospitals NHS Foundation Trust)
Solvemed’s smartphone-based device enables accurate pupil size and reactivity testing without additional plastic hardware, seamlessly uploading data to the EMR.
Regulated class I medical device.
Designed for maximum privacy and security.
Accuracy & reliability proven clinically.
Offers the trust you need when examining the brain.
No internet needed to conduct tests.
Faster to use than a traditional penlight.
We are proud to satisfy the needs of the world's leading practitioners across the spectrum of care.
In critical care settings, frequent pupil examination is of paramount importance. By assessing the size, symmetry, and reactivity of the pupils, healthcare professionals can gain valuable insights into the patient's neurological status. Abnormalities or changes in pupillary response can indicate brain injury, increased intracranial pressure, or other neurological issues.
Pupillometry is an easy-to-use non-invasive bedside technique to quantify nociception and monitor opioid effects. Specifically, pupil dilation reflex via automated increased tetanic stimulation may reflect opioid effect under general anaesthesia. Pupillometry has the potential to personalize pain management in perioperative and critical care unit environments and help monitor the depth of sedation.
Pupils are sensitive to a wide range of neurological diseases. Any damage to the brainstem, from bleeding, had injury or stroke, can squash the nerves, which can warn neurologists that a patient needs immediate brain surgery. For example, multiple sclerosis often reduces light signals that constrict the pupil, in a characteristic way, even when symptoms are minor. Damage to the nerves in the neck affect dilation, and can warn us about impending strokes. Also, a range of drugs can affect these pathways in distinctive ways, and can give a tell-tale sign that an unconscious patient may need life-saving drugs.
Nurses play a crucial role in patient care, and subjective pupil examination is an essential component of their monitoring toolkit. By regularly assessing pupils, nurses can detect early signs of patient deterioration, adverse drug reactions, or neurological changes. Monitoring changes in pupil helps nurses provide timely interventions, collaborate with healthcare teams, and ensure patient safety and well-being.
By quantifying the pupil light reflex, ophthalmologists can assess the functionality of the visual pathways and diagnose ocular diseases, including optic nerve disorders and severe retinal conditions, as well as trauma-related damage to the visual pathways and oculosympathetic denervation. Also, with the continuous development of refractive surgery, pupillometry has proven to be a useful tool both for evaluating and planning keratorefractive surgeries, and for the pre-operative assessment of intraocular lens placement.
Neuro-ophthalmologists specialize in diagnosing and managing conditions that affect both the eye and the nervous system. Pupil examination plays a critical role, as it helps identify optic nerve dysfunction, visual pathway abnormalities, or neurological disorders impacting vision. By evaluating pupillary responses, neuro-ophthalmologists can differentiate between various etiologies and develop tailor treatment.
We work closely with clinicians to develop game-changing tools that reshape clinical practice and research.
President of Ophthalmology Associates, ran the FDA’s pivotal Xalatan trial. Anterior segment surgeon, elected to membership in the prestigious Castroviejo Corneal Society.
Nobody tracks pupils accurately. Industry-wide standardised pupillary measurements are the future of care. There is high demand for a smartphone-enabled, reliable, scalable noninvasive diagnostic. This would be adopted across the entire industry."
Clinical Director Oxford Major Trauma Centre
With accurate, repeatable assessment of pupil size, this application could improve diagnosis of life-threatening complications of traumatic brain injury. This could reduce time to surgery, improve tertiary neurosciences services and deliver patient centred care.
Consultant Neuro-ophthalmologist and Ophthalmic Surgeon, University College London Hospitals, President of European Neuro-Ophthalmology Association
If an App could be developed allowing pupil measurements to be made using a smartphone then this would be hugely valuable and I predict would very quickly become part of standard clinical practice.
Neurologist and Clinical Researcher, Oxford University
Solvemed is likely to succeed because of its unique combination of scientists, programmers and clinicians working on the problem.
Consultant Ophthalmologist and Vitreoretinal Surgeon (Locum) at King’s College Hospital NHS Foundation Trust
The Solvemed AI penlight/pupillometer has the potential to modernise pupillary assessment and improve patient care.
Our ground-breaking smartphone-based approach enables scalable collection
of information-rich neurological biomarker datasets.
We are proud to spearhead interdisciplinary research collaborations to enable biomarker discoveries and improve patients’ health.
The latest company updates, scientific publications, and captivating articles.
Over the next few days our co-founders Hugo Chrost and Michal Wlodarski will be proudly representing Solvemed at the Neurocritical Care Society Annual Meeting in Phoenix, Arizona. With over 2,000 attendees, this event assembles the world's foremost community of Critical Care specialists and pioneering companies. All united with a singular vision: transforming the sector to be more efficient, accessible, and innovative. Solvemed’s Team is honored to be a part of such an incredible group!
Pupil reactivity testing system of choice for world's top practitioners.
We guarantee no spam. Only high-quality emails from our founders with valuable updates and exciting news.
.png)